Successes and Challenges in an Integrated Tuberculosis/HIV Clinic in a Rural, Resource-Limited Setting: Experiences from Kericho, Kenya

Table 4

Relationship of treatment success in patients starting antiretroviral therapy after TB treatment in the Kericho District Hospital TB/HIV Clinic (𝑛=684).

	Odds of treatment success (cure or treatment complete) versus death or loss to followup
Characteristic	Univariate model			Multivariate model^1
	OR	95% CI	P	OR	95% CI	P
Age
Adult	0.4	0.1–1.5	0.2	—	—	—
Pediatric	reference
Gender
Male	0.7	0.5–1.1	0.09	—	—	—
Female	reference
CD4 Category
≥50 cells/mm^3	2.0	1.3–3.1	<0.01	1.7	1.0–2.7	0.04
<50 cells/mm^3	reference			reference
CD4 Category
≥200 cells/mm^3	3.5	1.4–8.9	<0.01	2.4	0.9–6.3	0.09
<200 cells/mm^3	reference			reference
Time Until ART
≥2 weeks	1.9	1.0–3.5	0.05	1.3	0.6–2.7	0.5
<2 weeks	reference			reference
Time Until ART
≥2 months	2.0	1.3–3.3	<0.01	1.8	1.1–3.0	0.03
<2 months	reference			reference
Clinic Year
Year (2–5, 1 year increment)	1.2	1.0–1.5	0.02	1.3	1.1–1.6	<0.01
previous year	reference			reference

Notes:
OR: odds ratio, CI: confidence interval.
1Adjusted for CD4 categories, time until ART categories, and clinic year.